hemoglobin pegylated
Recombinant proteinexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01004198)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Hemoglobin beta chainSupplementation
HBB supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- hemoglobin pegylated
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01973504 | Phase 2 | Dec 1, 2013 | Sangart, University of London |
| NCT01262196 | Phase 2 | May 1, 2011 | Sangart, University of London |
| NCT01004198 | Phase 2 | Dec 1, 2009 | Sangart, University of London |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sangart | For profit | 3 | 3 | 1 | 2009 |
| University of London | Academic/Hospital | 3 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1